Qube Research & Technologies (QRT)
IMRX icon

Qube Research & Technologies (QRT)’s Immuneering IMRX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-165,875
Closed -$1.09M – 3804
2025
Q4 		$1.09M Buy
+165,875
New +$1.06M ﹤0.01% 2522
2024
Q4 		– Sell
-14,823
Closed -$36.9K – 3638
2024
Q3 		$36.9K Buy
14,823
+4,010
+37% +$5.83K ﹤0.01% 2904
2024
Q2 		$13.8K Buy
+10,813
New +$17.8K ﹤0.01% 2930
2023
Q1 		– Sell
-19,394
Closed -$94.1K – 2765
2022
Q4 		$94.1K Buy
19,394
+6,079
+46% +$53.8K ﹤0.01% 2020
2022
Q3 		$191K Sell
13,315
-2,627
-16% -$20.9K ﹤0.01% 1786
2022
Q2 		$86K Buy
+15,942
New +$85K ﹤0.01% 1988

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMRX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Immuneering (IMRX) in Q1 2026, closing a stake of 165,875 shares — an estimated $1.09M sold.

Qube Research & Technologies (QRT) first reported a position in IMRX in Q2 2022 and held it in 6 quarters. The position peaked at $1.09M in Q4 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Immuneering position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 165,875 Immuneering shares in Q1 2026, an estimated $1.09M.
  • Qube Research & Technologies (QRT) first reported a position in Immuneering in Q2 2022 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Immuneering position peaked at $1.09M in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.